Eagle Health Investments LP Astrazeneca PLC Transaction History

Eagle Health Investments LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $270,402 - $692,325	-5,100 Reduced 1.33%	377,965 $20.7 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $3.71 Million - $4.45 Million	-62,600 Reduced 14.05%	383,065 $25.3 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $9.25 Million - $11.1 Million	-166,000 Reduced 27.14%	445,665 $29.6 Million
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $8.76 Million - $10.3 Million	162,100 Added 36.06%	611,665 $35.6 Million
Q3 2021 Oct 20, 2021	BUY	$55.56 - $60.79 $2.77 Million - $3.03 Million	49,776 Added 12.45%	449,565 $27 Million
Q2 2021 Jul 19, 2021	BUY	$48.42 - $60.18 $2.08 Million - $2.59 Million	43,000 Added 12.05%	399,789 $23.9 Million
Q1 2021 Apr 23, 2021	BUY	$47.16 - $54.44 $5.97 Million - $6.9 Million	126,689 Added 55.06%	356,789 $17.7 Million
Q4 2020 Feb 04, 2021	BUY	$48.52 - $58.02 $11.2 Million - $13.4 Million	230,100 New	230,100 $11.5 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

Stay updated on Eagle Health Investments LP with notifications on news.